RS64469B1 - Kompozicije egzozoma i postupci za njihovu pripremu i primenu za regulisanje i kondicioniranje kože i kose - Google Patents

Kompozicije egzozoma i postupci za njihovu pripremu i primenu za regulisanje i kondicioniranje kože i kose

Info

Publication number
RS64469B1
RS64469B1 RS20230599A RSP20230599A RS64469B1 RS 64469 B1 RS64469 B1 RS 64469B1 RS 20230599 A RS20230599 A RS 20230599A RS P20230599 A RSP20230599 A RS P20230599A RS 64469 B1 RS64469 B1 RS 64469B1
Authority
RS
Serbia
Prior art keywords
exosomes
skin
heat shock
composition
cells
Prior art date
Application number
RS20230599A
Other languages
English (en)
Serbian (sr)
Inventor
John W Ludlow
Benjamin Buehrer
Peter Pieraccini
Original Assignee
Exotropin Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exotropin Llc filed Critical Exotropin Llc
Publication of RS64469B1 publication Critical patent/RS64469B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/92—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gerontology & Geriatric Medicine (AREA)
RS20230599A 2015-07-31 2016-07-28 Kompozicije egzozoma i postupci za njihovu pripremu i primenu za regulisanje i kondicioniranje kože i kose RS64469B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562199696P 2015-07-31 2015-07-31
EP16833569.3A EP3328397B1 (en) 2015-07-31 2016-07-28 Exosome compositions and methods for preparation and use thereof for regulating and conditioning skin and hair
PCT/US2016/044458 WO2017023690A1 (en) 2015-07-31 2016-07-28 Exosome compositions and methods for preparation and use thereof for regulating and conditioning skin and hair

Publications (1)

Publication Number Publication Date
RS64469B1 true RS64469B1 (sr) 2023-09-29

Family

ID=57943605

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20230599A RS64469B1 (sr) 2015-07-31 2016-07-28 Kompozicije egzozoma i postupci za njihovu pripremu i primenu za regulisanje i kondicioniranje kože i kose

Country Status (11)

Country Link
US (2) US20180147420A1 (enExample)
EP (2) EP3328397B1 (enExample)
JP (2) JP6980955B2 (enExample)
CA (2) CA2993224A1 (enExample)
ES (1) ES2952050T3 (enExample)
HR (1) HRP20230865T1 (enExample)
HU (1) HUE063486T2 (enExample)
PL (1) PL3328397T3 (enExample)
RS (1) RS64469B1 (enExample)
SM (1) SMT202300249T1 (enExample)
WO (2) WO2017023689A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11596656B2 (en) * 2016-08-23 2023-03-07 Albert Einstein College Of Medicine Stem cell-produced microvesicles for treating tendon pathologies
CN107080753A (zh) * 2017-04-20 2017-08-22 深圳市赛欧细胞生物科技有限公司 一种人脐带间充质干细胞源外泌体的美容制剂
CN107006452A (zh) * 2017-04-20 2017-08-04 深圳市赛欧细胞生物科技有限公司 一种人脐带间充质干细胞源外泌体冻干保存方法及其应用
CN107245472B (zh) * 2017-06-08 2021-08-06 北京智能宝生物科技有限公司 一种人间充质干细胞外泌体冻干粉的制备方法、使用方法
WO2019004738A2 (ko) * 2017-06-30 2019-01-03 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부염 개선 용도
WO2019004757A2 (ko) * 2017-06-30 2019-01-03 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 가려움증 억제 또는 개선 용도
KR20190003316A (ko) 2017-06-30 2019-01-09 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부염 개선 용도
WO2019040790A1 (en) 2017-08-23 2019-02-28 Merakris Therapeutics, Llc COMPOSITIONS CONTAINING AMNIOTIC COMPONENTS AND METHODS FOR THEIR PREPARATION AND USE
EP3681288B1 (en) * 2017-09-11 2025-11-26 Symbiocelltech, LLC Adaptation of hollow-fiber-based cell culture technology for the manufacturing of neo-islets or exosomes from stem cells
CN111527199A (zh) 2017-11-16 2020-08-11 得克萨斯大学体系董事会 用于制备来源于msc的外泌体的方法
KR20190060646A (ko) 2017-11-24 2019-06-03 주식회사 엑소코바이오 줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
WO2019103381A1 (ko) * 2017-11-24 2019-05-31 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
KR102039302B1 (ko) * 2017-11-24 2019-10-31 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
US12036325B2 (en) 2017-12-14 2024-07-16 Mayo Foundation For Medical Education And Research Purified exosome products, method of making, and methods of using
WO2019139762A1 (en) * 2018-01-09 2019-07-18 Zen-Bio, Inc. Exosome compositions and use thereof for joint disorders and diseases
JP7474702B2 (ja) 2018-03-28 2024-04-25 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム エキソソームから単離されたｄｎａにおけるエピジェネティック変化の同定法
US20210244769A1 (en) * 2018-05-04 2021-08-12 Figene, Llc Pain-reducing effects of fibroblasts and treatment of pain
RU2710368C2 (ru) * 2018-05-29 2019-12-26 Станислав Евгеньевич Волчков Способ получения и концентрирования микроРНК-содержащих экзосом мультипотентных мезенхимально-стромальных клеток для применения в косметических и лекарственных средствах для стимуляции регенеративных процессов и замедления процессов старения
US12453743B2 (en) 2018-05-30 2025-10-28 Direct Biologics, Llc Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
KR102646145B1 (ko) * 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
WO2019231133A1 (ko) * 2018-05-31 2019-12-05 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
CN108715834B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种富含cd41+、cd81+微囊的血小板裂解液制备方法
KR102176845B1 (ko) * 2018-10-02 2020-11-10 주식회사 스템온 유도된 엑소좀을 포함하는 피부 재생 및 상처 치유용 조성물
EP3930734A4 (en) 2019-02-28 2022-12-07 Merakris Therapeutics, LLC EXTRACELLULAR VESICLES DERIVED FROM AMBIENT WATER AND THEIR USES IN WOUND HEALING
WO2020180311A1 (en) * 2019-03-06 2020-09-10 Zen-Bio, Inc. Plant-based exosome compositions and use thereof for rejuvenating skin
CA3138177A1 (en) * 2019-04-29 2020-11-05 Direct Biologics Llc Method for the treatment of periodontal disease using characterized mesenchymal stem cell growth factors and exosomes
EP3999083A4 (en) 2019-07-18 2023-07-26 Direct Biologics LLC Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
JP2021040551A (ja) * 2019-09-11 2021-03-18 富士フイルム株式会社 培地組成物、キット、間葉系幹細胞組成物の製造方法、間葉系幹細胞組成物、間葉系幹細胞、細胞培養上清および細胞外小胞
CN110559254A (zh) * 2019-10-20 2019-12-13 张新梅 一种外泌体组合物、其制备方法及应用
CA3160078A1 (en) * 2019-11-04 2021-05-14 Omar Mohamed Salah Eldin Ahmed ELTOOKHY Method for coating and drying heterogenous stem cell derived extra-cellular vesicles
CN110721198A (zh) * 2019-11-08 2020-01-24 赵凯 一种预防癫痫产生脑损伤的外泌体喷雾的制作工艺
WO2021147922A1 (zh) 2020-01-20 2021-07-29 医微细胞生物技术(广州)有限公司 细胞外囊泡及其在皮肤产品的用途
CN113134014B (zh) * 2020-01-20 2023-09-26 医微细胞生物技术(广州)有限公司 囊泡在制备血友病药物中的应用
US12077780B2 (en) 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
US20240390551A1 (en) * 2021-01-20 2024-11-28 Research & Business Foundation Sungkyunkwan University Filler composition for reducing skin wrinkles comprising stem cell-derived exosomes, hyaluronic acid, and bdde and method for preparing same
KR102368442B1 (ko) * 2021-02-19 2022-02-28 주식회사 엑소코바이오 생리활성이 강화된 엑소좀의 생산방법 및 이의 응용
TW202235614A (zh) * 2021-03-11 2022-09-16 長新生醫國際股份有限公司 幹細胞凍乾粉之製造方法
CN113041259B (zh) * 2021-03-23 2023-05-12 哈尔滨科技实业开发有限公司 牙髓干细胞外泌体制剂及制备方法和应用
CA3213489A1 (en) * 2021-03-31 2022-10-06 Giorgio Dell'acqua Compositions comprising plant-derived exosome-like nanovesicles or exosomes and methods of use thereof
CN113384518A (zh) * 2021-07-27 2021-09-14 山西遗传资源细胞库有限公司 一种干细胞外泌体应用于面膜的方法
JPWO2023079655A1 (enExample) * 2021-11-04 2023-05-11
CN113940912B (zh) * 2021-12-09 2024-04-16 深圳市泓浩生物科技有限公司 抗衰老的组合物及其应用
CN116099056A (zh) * 2023-04-07 2023-05-12 云南云科特色植物提取实验室有限公司 一种含仿生纹理结构的人工皮肤及其制备方法
CN116410918B (zh) * 2023-06-12 2023-08-25 成都诺医德医学检验实验室有限公司 一种皮肤类器官外泌体及其制备方法和应用
WO2025030027A1 (en) * 2023-08-03 2025-02-06 Wisconsin Alumni Research Foundation Extracellular vesicle therapy to treat orthopedic injury
CN118576721A (zh) * 2024-05-27 2024-09-03 深圳市中安康华生物科技有限公司 一种外泌体复合生物制剂及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348945A (en) * 1990-04-06 1994-09-20 Wake Forest University Method of treatment with hsp70
US5593682A (en) * 1995-12-29 1997-01-14 Eastman Chemical Company Skin treating composition
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
JP2004331602A (ja) * 2003-05-09 2004-11-25 Arysta Lifescience Corp 皮膚外用剤
EP1514539A3 (en) * 2003-05-14 2005-05-04 Signal Investment & Management Co. Micro-encapsulated topical analgesic for pain relief and sleeve comprising it
US20060143782A1 (en) * 2004-10-07 2006-07-06 Sherry Ajluni Glove with skin lotion
US8022037B2 (en) * 2007-01-08 2011-09-20 University Of Southern California Skin wound healing compositions and methods of use thereof
US20110003008A1 (en) * 2008-02-22 2011-01-06 Agency For Science, Technology And Research (A*Star) Mesenchymal stem cell particles
CN103118691B (zh) * 2010-08-23 2016-08-24 康干细胞生物科技有限公司 预防和治疗免疫病变和炎性疾病的包括用nod2激动剂处理的干细胞或其培养物的药物组合物
JP5911874B2 (ja) * 2010-10-18 2016-04-27 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 発毛を促進又は増強するためのエキソソームの使用
US9119974B2 (en) * 2011-03-04 2015-09-01 Ahmed H. Al-Qahtani Skin cream
CN109432126B (zh) * 2011-03-11 2022-06-14 儿童医学中心公司 与间充质干细胞外来体相关的方法和组合物
JP3171007U (ja) * 2011-06-28 2011-10-13 ヘルスアシスト株式会社 腕肩美容パックシート
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
EP2687219A1 (en) * 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
CN105209881B (zh) * 2013-03-13 2021-01-22 迈阿密大学 从细胞培养上清液和生物流体分离并纯化微泡的方法
WO2014197747A1 (en) * 2013-06-05 2014-12-11 The Trustees Of Columbia University In The City Of New York Exosomes for orofacial diagnostics and therapeutics
JP6253361B2 (ja) * 2013-11-21 2017-12-27 ポーラ化成工業株式会社 皮膚外用剤
JP2015101541A (ja) * 2013-11-21 2015-06-04 ポーラ化成工業株式会社 皮膚関連酵素活性化剤
US9464272B2 (en) * 2013-12-12 2016-10-11 Stemnion, Inc. Cell-derived composition
CN104488850B (zh) * 2014-11-28 2016-11-02 广州赛莱拉干细胞科技股份有限公司 一种制备人羊膜间充质干细胞外泌体冻干粉的方法

Also Published As

Publication number Publication date
EP3328403A1 (en) 2018-06-06
JP6719559B2 (ja) 2020-07-08
EP3328397C0 (en) 2023-07-12
EP3328397B1 (en) 2023-07-12
CA2993227C (en) 2020-07-21
CA2993227A1 (en) 2017-02-09
WO2017023689A1 (en) 2017-02-09
US20180177828A1 (en) 2018-06-28
EP3328397A1 (en) 2018-06-06
PL3328397T3 (pl) 2023-10-16
HRP20230865T1 (hr) 2023-11-10
ES2952050T3 (es) 2023-10-26
HUE063486T2 (hu) 2024-01-28
US20180147420A1 (en) 2018-05-31
EP3328403A4 (en) 2019-04-17
JP2018522593A (ja) 2018-08-16
JP2018522071A (ja) 2018-08-09
JP6980955B2 (ja) 2021-12-15
CA2993224A1 (en) 2017-02-09
WO2017023690A1 (en) 2017-02-09
EP3328397A4 (en) 2019-04-03
SMT202300249T1 (it) 2023-09-06

Similar Documents

Publication Publication Date Title
JP6719559B2 (ja) 軟組織修復のための、エキソソーム組成物およびその使用
Borena et al. Regenerative skin wound healing in mammals: state-of-the-art on growth factor and stem cell based treatments
Li et al. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway
US10639264B2 (en) Mesenchymal stem cell extract and its use
Park et al. Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration
CN108699519A (zh) 干细胞衍生的含有大量生长因子的外来体
JP2022020814A (ja) 幹細胞性維持及び賦活化剤、並びにそれを含有する皮膚外用剤及び化粧品
Al-Shaibani et al. Cellular therapy for wounds: applications of mesenchymal stem cells in wound healing
Wang et al. Adipose‐derived stem cells enriched with therapeutic mRNA TGF‐β3 and IL‐10 synergistically promote scar‐less wound healing in preclinical models
Yang et al. The therapeutic application of stem cells and their derived exosomes in the treatment of radiation-induced skin injury
Nouri et al. Application of mesenchymal stem cells and exosome alone or combination therapy as a treatment strategy for wound healing
Tai et al. Secretome profile of TNF-α-induced human umbilical cord mesenchymal stem cells unveils biological processes relevant to skin wound healing
US20160075995A1 (en) Sweat gland-derived stem cells and methods of use
Kee et al. Umbilical Cord Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Skin Matrix Synthesis and Pigmentation
KR20250037691A (ko) 중간엽 줄기세포 스페로이드, 이의 제조방법 및 이를 포함하는 조성물
Zheng et al. Experimental study on the effect and mechanism of adipose stem cell‐derived exosomes combined with botulinum toxin A on skin trauma in rats
Gurney et al. Modulation of ASC-derived extracellular vesicles containing cargo that specifically enhances wound healing
Aberdam et al. Extracellular vesicles including exosomes for hair follicle regeneration
Yan et al. hucMSC-derived exosomes ameliorate pressure ulcers by inhibiting HMGB1.
Bulut et al. Regenerative effect of lyophilized dental follicle mesenchymal stem cells and platelet-rich fibrin in skin wounds in geriatric and young rats
Rosca et al. Mesenchymal Stromal Cells for Wound Healing Therapy: From Expectations to Reality
Zheng et al. Integrating Stem Cell Biology and Organoid Technology for Skin Regenerative Therapies
RU2719513C1 (ru) Способ стимуляции репаративного ангиогенеза и регенерации кожного покрова собак при его повреждении методом генной терапии с использованием видоспецифичных генов белковых факторов vegf и fgf2 в ветеринарии и генетическая конструкция для реализации заявленного способа
Huynh et al. A mixture of secretions and extractions derived from antler stem cells heal open wounds in rats with a tendency to leave no scar
CN119530145A (zh) Adsc外泌体在调控il33分泌中的应用